AstraZeneca plc (AZN) Stock Price Today
DNO ASA's offer for Capricorn Energy plc lapses, ending the acquisition attempt.
DNO ASA announced that its offer to acquire Capricorn Energy plc has lapsed as of November 9, 2026. This means the acquisition attempt will not proceed, impacting DNO's expansion plans in the oil and gas sector. Investors should monitor DNO's next st...

Oculis to host R&D Day showcasing late-stage pipeline for dry eye and neuro-ophthalmology treatments
Oculis Holding AG announced an in-person and virtual R&D Day on December 8, 2026, to highlight key clinical developments in its late-stage pipeline, including Licaminlimab for dry eye disease and Privosegtor for neuro-ophthalmology and neurology. The...

Fraudulent robocall losses in North America to drop 33% by 2031 due to advanced fraud prevention.
Juniper Research forecasts that losses from fraudulent robocalls in North America will decrease by 33%, from $18.4 billion in 2026 to $12.3 billion in 2031. This decline is attributed to telecom operators adopting advanced fraud prevention technologi...

Novo Nordisk beats Q3 expectations, showing strong growth and a 34% upside potential.
Novo Nordisk's Q3 results exceeded expectations, driven by a 53% increase in pill sales and strong net patient growth, dispelling fears of oral product cannibalization. The company is also reducing capital expenditures and expanding free cash flow, s...

VAALCO Energy advances to second exploration phase at Côte d'Ivoire Block CI-705 after successful initial work.
VAALCO Energy has completed the First Exploration Phase at Block CI-705 offshore Côte d'Ivoire and received government approval to proceed to the Second Exploration Phase. The block, where VAALCO holds a 70% interest, is located near existing oil fie...

OTC Markets appoints Olivier Roguez as VP to boost market data growth in EMEA.
OTC Markets Group named Olivier Roguez Vice President, Market Data for the EMEA region to lead business development and market data growth. Roguez brings over 20 years of experience from Cboe Global Markets and other firms, aiming to expand OTC Marke...

Dapirolizumab pegol shows higher response rates and sustained remission in SLE patients versus placebo in Phase 3 trial.
Dapirolizumab pegol (DZP), an investigational biologic for systemic lupus erythematosus (SLE), demonstrated greater treatment response rates compared to placebo when combined with standard care in the Phase 3 PHOENYCS GO trial. Using a novel Treatmen...

ClearPoint Neuro posts strong Q3 with rising drug delivery revenue and promising future trials.
ClearPoint Neuro reported solid third-quarter results, driven by increased revenue from its drug delivery services and steady sales in neurosurgery navigation equipment. The company sees encouraging signs for future growth in disposables linked to ca...

Investor uses technical analysis to target small-cap biotech stocks with promising Phase 2 progress.
David H. Lerner focuses on long-term biotech investments using technical analysis, emphasizing price action and volume rather than traditional fundamentals. He targets small-cap biotech companies advancing beyond Phase 2 trials, especially those deve...

Berkshire Hathaway holds more cash than stocks, signaling Buffett's cautious investment approach.
Berkshire Hathaway reported $377.4 billion in cash and Treasury bills, exceeding its $335.5 billion stock holdings as of Q3 2026. Warren Buffett maintains this large cash reserve as a safety floor against market downturns and to fund future acquisiti...

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.